A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 03 Apr 2017
At a glance
- Drugs Letrozole (Primary) ; Palbociclib (Primary)
- Indications Early breast cancer
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms PALLET
- 07 Jun 2017 Biomarkers information updated
- 27 Mar 2017 Planned End Date changed from 31 Aug 2018 to 31 Oct 2017.
- 01 Nov 2016 Planned End Date changed from 15 Dec 2017 to 31 Aug 2018.